← Back to Search

ALTENS for Dry Mouth in Head and Neck Cancer Patients

N/A
Recruiting
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Minimum of 3 months post initial curative therapy with no evidence of active disease by standard of care surveillance scans for said disease site
Previous radiation to the head and neck with a dose > 50 Gy
Must not have
Age under 18 years of age
Severe COPD with exacerbation causing hospitalization within the last 6 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if using small electrical currents on specific body points can help patients with head and neck cancer who have had radiation treatment to reduce their dry mouth symptoms. This method has been used for skin tumors and has been evaluated for its effectiveness and safety in head and neck cancers.

Who is the study for?
This trial is for adults over 18 with dry mouth after radiation therapy for head and neck cancer. They must be at least 3 months post-treatment, without active cancer, and able to attend a 12-week ALTENS therapy program. It's not suitable for those with recent severe heart issues, implanted electronic devices, or who are pregnant.
What is being tested?
The study tests if acupuncture-like electrical stimulation (ALTENS) can relieve dry mouth in patients who've undergone radiation for head and neck cancers. Participants will receive ALTENS therapy over a period of 12 weeks to evaluate its effectiveness.
What are the potential side effects?
While the side effects of ALTENS aren't detailed here, similar treatments may cause mild discomfort or skin irritation at the site of electrode placement. Serious side effects are rare but could include aggravation of existing symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
It's been over 3 months since my last treatment and my scans show no active cancer.
Select...
I have received radiation treatment to my head or neck area with a dose over 50 Gy.
Select...
I do not have any active cancer in my head or neck area.
Select...
I am older than 18 years.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.
Select...
I was hospitalized for a severe COPD flare-up in the last 6 months.
Select...
I have had heart rhythm problems in the last 6 months.
Select...
I have not been hospitalized for heart problems in the last 6 months.
Select...
I cannot attend ALTENS therapy sessions.
Select...
I have unstable chest pain.
Select...
I am willing and able to undergo chemoradiation therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of patients with a mean parotid dose > 25 Gy have an improvement on the XeQoL questionnaire that is significantly different than those with a mean dose < 25 Gy
Secondary study objectives
Incidence of Treatment-Related Adverse Events [Safety and Tolerability]

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Experimental: Acupuncture-Like Transcutaneous Electrical Stimulation (ALTENS) TherapyExperimental Treatment1 Intervention
Six (6) small electrodes will be placed on specific points of the body using adhesive pads. These electrodes are connected to the ALTENS device, which will send controlled, low-level electrical impulses through the skin and into the tissue underneath.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for head and neck cancers include surgery, radiation therapy, chemotherapy, and integrative therapies like acupuncture and acupuncture-like electrical therapy. Surgery and radiation therapy primarily work by physically removing or destroying cancer cells. Chemotherapy uses drugs to kill rapidly dividing cells, including cancer cells. Acupuncture-like electrical therapy, such as the stimulation of salivary gland function, aims to alleviate symptoms like xerostomia (dry mouth) by enhancing salivary flow through electrical stimulation of the nerves and tissues associated with salivary glands. Understanding these mechanisms is crucial for patients as it helps them comprehend how each treatment targets their cancer or alleviates symptoms, enabling informed decisions about their care.
A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma.Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial.

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
867 Previous Clinical Trials
548,807 Total Patients Enrolled

Media Library

Acupuncture-Like Transcutaneous Electrical Stimulation (ALTENS) Clinical Trial Eligibility Overview. Trial Name: NCT04805528 — N/A
Head and Neck Cancers Research Study Groups: Experimental: Acupuncture-Like Transcutaneous Electrical Stimulation (ALTENS) Therapy
Head and Neck Cancers Clinical Trial 2023: Acupuncture-Like Transcutaneous Electrical Stimulation (ALTENS) Highlights & Side Effects. Trial Name: NCT04805528 — N/A
Acupuncture-Like Transcutaneous Electrical Stimulation (ALTENS) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04805528 — N/A
~12 spots leftby May 2025